Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46.1M
-
Number of holders
-
255
-
Total 13F shares, excl. options
-
42.7M
-
Shares change
-
+346K
-
Total reported value, excl. options
-
$1.03B
-
Value change
-
+$11.5M
-
Put/Call ratio
-
0.93
-
Number of buys
-
96
-
Number of sells
-
-108
-
Price
-
$24.03
Significant Holders of AVANOS MEDICAL, INC. - Common Stock (AVNS) as of Q3 2024
290 filings reported holding AVNS - AVANOS MEDICAL, INC. - Common Stock as of Q3 2024.
AVANOS MEDICAL, INC. - Common Stock (AVNS) has 255 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42.7M shares
of 46.1M outstanding shares and own 92.59% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (7.05M shares), VANGUARD GROUP INC (5.32M shares), RGM Capital, LLC (3.17M shares), DIMENSIONAL FUND ADVISORS LP (2.59M shares), T. Rowe Price Investment Management, Inc. (2.37M shares), WESTWOOD HOLDINGS GROUP INC (1.99M shares), STATE STREET CORP (1.82M shares), BROWN ADVISORY INC (1.7M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1.38M shares), and Paradice Investment Management LLC (1.26M shares).
This table shows the top 255 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.